CRVO · CervoMed Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 1.55 USD |
|---|---|
| 1-day change | -5.5% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 4 / 11 / 10 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 1 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.4% |
| Market cap (USD) | $35.6M |